title: Regulatory scientific advice on non-inferiority drug trials.
abstract: The active-controlled trial with a non-inferiority design has gained popularity in recent years. However, non-inferiority trials present some methodological challenges, especially in determining the non-inferiority margin. Regulatory guidelines provide some general statements on how a non-inferiority trial should be conducted. Moreover, in a scientific advice procedure, regulators give companies the opportunity to discuss critical trial issues prior to the start of the trial. The aim of this study was to identify potential issues that may benefit from more explicit guidance by regulators. To achieve this, we collected and analyzed questions about non-inferiority trials posed by applicants for scientific advice in Europe in 2008 and 2009, as well as the responses given by the European Medicines Agency (EMA). In our analysis we included 156 final letters of advice from 2008 and 2009, addressed to 94 different applicants (manufacturers). Our analysis yielded two major findings: (1) applicants frequently asked questions 'whether' and 'how' to conduct a non-inferiority trial, 26% and 74%, respectively, and (2) the EMA regulators seem mainly concerned about the choice of the non-inferiority margin in non-inferiority trials (36% of total regulatory answers). In 40% of the answers, the EMA recommended using a stricter margin, and in 10% of the answers regarding non-inferiority margins, the EMA questioned the justification of the proposed non-inferiority margin. We conclude that there are still difficulties in selecting the appropriate methodology for non-inferiority trials. Straightforward and harmonized guidance regarding non-inferiority trials is required, for example on whether it is necessary to conduct such a trial and how the non-inferiority margin is determined. It is unlikely that regulatory guidelines can cover all therapeutic areas; therefore, in some cases regulatory scientific advice may be used as an opportunity for tailored advice.
authors.affiliation: Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands ; Medicines Evaluation Board, Utrecht, The Netherlands.
authors.forename: Grace
authors.initials: G
authors.lastname: Wangge
authors.forename: Michelle
authors.initials: M
authors.lastname: Putzeist
authors.forename: Mirjam J
authors.initials: MJ
authors.lastname: Knol
authors.forename: Olaf H
authors.initials: OH
authors.lastname: Klungel
authors.forename: Christine C
authors.initials: CC
authors.lastname: Gispen-De Wied
authors.forename: Antonius
authors.initials: A
authors.lastname: de Boer
authors.forename: Arno W
authors.initials: AW
authors.lastname: Hoes
authors.forename: Hubert G
authors.initials: HG
authors.lastname: Leufkens
authors.forename: Aukje K
authors.initials: AK
authors.lastname: Mantel-Teeuwisse
mesh_terms: D018849:Controlled Clinical Trials as Topic / Q000331:legislation & jurisprudence* / Q000379:methods* / Q000706:statistics & numerical data; D004345:Drug Industry / Q000592:standards; D004358:Drug Therapy / Q000379:methods* / Q000592:standards; D005060:Europe; D004364:Pharmaceutical Preparations / Q000592:standards*; D011786:Quality Control; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D004364:Pharmaceutical Preparations
references.citation: Ann Intern Med. 2000 Sep 19;133(6):455-63
references.pmid: 10975964
references.citation: Ann Pharmacother. 2008 Nov;42(11):1605-12
references.pmid: 18957629
references.citation: Clin Pharmacol Ther. 2010 Sep;88(3):420-3
references.pmid: 20668448
references.citation: Stat Med. 2006 May 30;25(10):1628-38
references.pmid: 16639773
references.citation: Pharm Stat. 2008 Apr-Jun;7(2):77-87
references.pmid: 18438957
references.citation: Drug Discov Today. 2013 Jun;18(11-12):601-4
references.pmid: 23328201
references.citation: Eur J Clin Pharmacol. 2011 Feb;67(2):157-64
references.pmid: 21049297
references.citation: Lancet. 2007 Dec 1;370(9602):1875-7
references.pmid: 17959239
references.citation: Thromb Res. 2013 Apr;131(4):368-71
references.pmid: 23466215
references.citation: Stat Med. 2002 Oct 15;21(19):2931-8
references.pmid: 12325109
references.citation: PLoS One. 2010 Oct 27;5(10):e13550
references.pmid: 21048948